- ￥173 - 797
- TargetMol
- T0267
- 2026年07月07日
2 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号：
68291-97-4
- 规格：
1mLx10mM(inDMSO)/50mg/100mg/200mg/500mg
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥173.0 |
|---|---|---|---|
| 规格： | 50mg | 产品价格： | ￥294.0 |
| 规格： | 100mg | 产品价格： | ￥389.0 |
| 规格： | 200mg | 产品价格： | ￥545.0 |
| 规格： | 500mg | 产品价格： | ￥797.0 |
Product Introduction
Bioactivity
| 名称 | Zonisamide |
| 描述 | Zonisamide (AD 810), a sulfonamide anticonvulsant, is approved for use as an adjunctive treatment in adults with partial-onset seizures. It may inhibit a carbonic anhydrase although this is not one of the main mechanisms of action. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels results in a reduction of T-type calcium channel currents, or by binding allosterically to GABA receptors. This latter action may lower the uptake of the inhibitory neurotransmitter GABA while increasing the uptake of the excitatory neurotransmitter glutamate. |
| 体外活性 | Zonisamide可影响多巴胺活性,为缺血小鼠模型提供保护,并影响抗氧化系统.Zonisamide减缓DA代谢物DOPAC、DA和酪氨酸羟化酶在弱纹状体中含量的降低速度.Zonisamide（10和30 mg/kg）通过剂量依赖的方式产生止痛作用和抗痛觉过敏,这些作用分别通过机械刺激(von Frey测试法)和响应热刺激(足底痛觉测试)的撤回阈值提高得到证明.在未结扎小鼠体内,Zonisamide对严重的热刺激和机械伤害具有镇痛作用.在大鼠体内,Zonisamide使纹状体体积从载体处理对照组的78%降低为8%,皮质梗死体积从68%降低为6%.在大鼠体内, Zonisamide也会降低5个海马区(脑下脚,CA3,CA1,CA4,和齿状回)的神经元坏死.在患有海马癫痫的大鼠体内,Zonisamide使脑皮层和海马体中EAAC-1蛋白质数量增加,并下调GABA转运蛋白GAT-1. 在乌拉坦麻醉的大鼠体内,Zonisamide抑制50 mM KCl诱发的海马谷氨酸释放,AUC 为60 min,使之从9.2 mM降低为5.8 mM,也会抑制Ca2+对KCl诱发的海马谷氨酸释放的刺激作用. |
| 体内活性 | Zonisamide对体外单胺氧化酶B活性具有抑制作用,IC50为25 μM。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 250 mg/mL (1177.97 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (47.12 mM), Solution. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (9.42 mM), Sonication is recommended. |
| 关键字 | Zonisamide | SodiumChannel | Sodium Channel | SH-SY5Y | seizure | parkinson's disease | NRCMs | Inhibitor | inhibit | epilepsy | CI-912 | CI912 | cardiac hypertrophy | cardiac fibroblasts | CarbonicAnhydrase | Carbonic Anhydrase | Carbonate dehydratase | CalciumChannel | Calcium Channel | Apoptosis | AD-810 | AD810 |
| 相关产品 | Formamide | Urea | Dimethyl phthalate | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Sodium Dihydrogen Phosphate | Metronidazole | 2,4,6-Tri-tert-butylphenol | Sildenafil citrate | Stavudine | Tamoxifen |
| 相关库 | Bioactive Compound Library | Bioactive Compounds Library Max | EMA Approved Drug Library | Failed Clinical Trials Compound Library | Ion Channel Targeted Library | FDA-Approved Drug Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Pain-Related Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
技术资料暂无技术资料 索取技术资料
文献支持
唑尼沙胺【68291-97-4】
￥173 - 797
